Explore the future of precision medicine in the region at PMES 23 this month

May 23, 2023 by
Explore the future of precision medicine in the region at  PMES 23 this month

Leading healthcare experts from MENA and beyond to explore the future of precision medicine in the region at  PMES 23 this month

The future of medicine in the Middle East and North Africa is precise
By 2030, the global market for precision medicine is expected to exceed $175bn
PMES 23 is generously supported by the UAE’s MoIAT, MoHAP, DoH Abu Dhabi, and the DHA
PMES 23 takes place 23-24 May 2023 at the Dubai World Trade Centre

The Middle East’s leading event dedicated to the advancement of precision medicine in the region is set to welcome a distinguished lineup of healthcare leaders and experts from around the world later this month. 

Returning to the United Arab Emirates, the 2023 edition of the PrecisionMed Exhibition & 
Summit (PMES) takes place 23-24 May 2023 at the Dubai World Trade Centre.
Bringing together key figures in the field of precision medicine, PMES 23 will offer a unique 
platform for knowledge sharing and collaboration by reviewing the practical application of 
precision medicine and encouraging clinical adoption. Attendees can expect engaging 
discussions, insightful presentations, and interactive exhibits showcasing the latest 
breakthroughs and technologies in precision medicine.

PMES 23 is generously supported by the UAE’s Ministry of Industry and Advanced 
Technology (MoIAT), Ministry of Health and Prevention (MoHAP), Department of Health 
(DoH) Abu Dhabi, and the Dubai Health Authority (DHA).

David Stradling, Managing Director of the PrecisionMed Exhibition & Summit (PMES), 
stated: “In 2022, the global market was valued at about $73.5 billion; by 2030, we will 
exceed $175 billion. Developed markets are being serviced by companies in this space and 
they are now turning to the significant opportunities offered by the Middle East and North 
Africa where genetic screening is in growing demand.”

Aisha Al Mulla, Director of Friends of Cancer Patients in the UAE, added: “The 
endorsement of the integration of personalised and precision medicine can improve the 
diagnostics, drug therapy and health outcomes by tailoring the treatment plan to the needs 
of each cancer patient.”

Focusing on adoption, the PMES 23 summit will feature informed presentations and debate,
with conference speakers exploring the real-world application of genetics and genomebased systems, and the movement towards customised healthcare to tackle disease and 
benefit patients. The PMES 23 exhibition, meanwhile, will showcase a host of healthcare 
providers, companies and other organisations demonstrating their latest cutting-edge 
 technology in precision medicine, serving as a catalyst to drive progress in personalised 
healthcare solutions.

The PMES represents an unparalleled opportunity for industry professionals, researchers, 
clinicians, and policymakers to exchange ideas, foster partnerships, and shape the future of 
healthcare in the region.

The opening ceremony of PMES 23 is set to feature appearances by Her Excellency Sarah Al 
Amiri, UAE Minister of State for Public Education and Advanced Technology; Dr. Asma Al 
Mannaei, Executive Director Research and Innovation Center at the DoH Abu Dhabi; Dr. 
Yendry Ventura, CEO of Abu Dhabi Stem Cells Center; Saba Samir Flaihan Hamasha, part of 
the patient support group for the UAE Rare Disease Society; and Dr. Khalid Fakhro, Chief 
Research Officer at Sidra Medicine, Qatar.

International guests attending and presenting include Dr. Jun Takahashi, Director and 
Professor of the Center for iPS Cell Research and Application (CiRA) at Kyoto University; Dr. 
Masayo Takahashi, President of Vision Care, Japan; Dr. Imane Boudellioua, Assistant 
Professor in the Information and Computer Science Department at King Fahd University of 
Petroleum and Minerals, KSA; Dr. Abeer Alsayegh, Sultan Qaboos Comprehensive Cancer 
Care and Research Centre (SQCCCRC), Oman; and Professor Mingguang, Principal 
Investigator at Centre for Eye Research Australia.

Co-located with EMERGE 2050
Taking place simultaneously with PMES 23 is EMERGE 2050, a forum dedicated to innovation 
and investment in healthtech. EMERGE 2050’s mission is to connect technology disruptors at 
startup and scale-up stage with the capital and partnering needed to take projects to 
fruition. The event also aims to address the potential held by digital and telehealth in 
mitigating the overwhelming costs of incumbent systems. Healthtech presents a significant 
opportunity to enhance the sustainability of healthcare.

PMES 23 co-located with EMERGE 2050 is supported and sponsored by One Health, Abu 
Dhabi Stem Cells Center (ADSCC), Cleveland Clinic Abu Dhabi, Sheikh Shakhbout Medical City 
(SSMC), Abu Dhabi Health Services Company (SEHA), Leader Life Sciences, Thermo Fisher
Scientific, Biorus and the Technology Innovation Institute (TII).

PMES 23 and EMERGE 2050 takes place on 23-24 May 2023 at Sheikh Rashid Hall at the 
Dubai World Trade Centre from 9am to 6pm. For more information, and to register to 
attend, visit https://precisionmedexpo.com/ and emergeghi.com.